Rheinmetall’s Record Orders Can’t Mask a Harsh New Reality on the Stock Market
Published on 07/09/2026 at 12:45 | Redaktion boerse-global.de
For a company that just booked a €270 million contract extension for the Lynx infantry fighting vehicle and is building the first ATACMS missile plant outside the United States, Rheinmetall shares are behaving as if none of it matters. The Düsseldorf-based defence group closed Wednesday at €1,063.20 before sliding another 3.91 percent on Thursday to €1,021.60 — a move that brought the year-to-date decline to 36.21 percent. At 49 percent below its September 2025 all-time high of €1,995, the stock is trading in a territory that no amount of order-book optimism seems able to lift.
The operational picture tells a markedly different story. In the first quarter, revenue climbed 8 percent to €1.938 billion, operating profit jumped 17 percent to €224 million, and the order backlog swelled to a record €73 billion. Rheinmetall also deepened its partnership with Renk through the Lynx KF41 driveline contract, worth more than €270 million including options, and alongside Lockheed Martin began establishing a production line for ATACMS guided missiles in Unterlüß, Lower Saxony — the first such facility outside the US.
But the market is no longer rewarding headline-grabbing announcements. The quarterly sales figure missed analyst expectations of roughly €2.3 billion by a wide margin, and the margin conversion story remains a work in progress. MWB Research analyst Jens-Peter Rieck recently downgraded the stock from Buy to Hold, slashing his target price to €1,150, a level that still implies only modest upside from current levels.
The F126 scar that won’t heal
The single event that broke the bullish narrative was the German defence ministry’s decision in June to scrap the F126 frigate programme. Originally budgeted at around €10 billion, the project’s costs had ballooned to more than €18 billion before Defence Minister Boris Pistorius pulled the plug. Rheinmetall’s direct exposure was limited to a few hundred million euros in lost revenue this year, but the symbolic damage was far greater. For investors who had bet on a long-term surge in European defence spending, the F126 cancellation sent a chilling message: even politically vital programmes can be killed when costs spiral.
Should investors sell immediately? Or is it worth buying Rheinmetall?
That message has taken root. The relative strength index now sits at 39.5, deep in oversold territory, yet the stock has failed to bounce in any meaningful way. The 30-day volatility of 69.71 percent — more typical of a biotech spec stock than a DAX heavyweight — reflects a market that has lost confidence in the reliability of Germany’s budget promises. At a price-to-earnings ratio of 30, the valuation still embeds a fair amount of optimism, but the premium investors once paid for any “Zeitenwende” story has evaporated.
A sector-wide reassessment
Rheinmetall is hardly alone in its misery. Hensoldt, Renk, and AeroVironment have also seen their shares slide despite reporting record or near-record order backlogs. Renk, for instance, posted a first-quarter order intake of €582.3 million and a backlog of €6.9 billion, yet its stock has lost 20.8 percent since the start of the year. The pattern is consistent: the market is now demanding that order books convert into cash flow and margins, not just be brandished as trophies.
For Rheinmetall, the task ahead is to prove that the ATACMS cooperation and the Lynx extension are more than political symbolism. The federal cabinet’s draft 2027 budget, which allocates nearly €140 billion to defence, provides a funding floor, but it does not guarantee that every project will survive cost reviews. The gap between the current share price and the 200-day moving average of €1,526.90 remains a chasm of more than 30 percent.
Rheinmetall at a turning point? This analysis reveals what investors need to know now.
The next catalyst is likely to be the half-year report at the end of July, where investors will scrutinise whether margins are expanding in line with revenue growth. Until then, Rheinmetall’s shares are caught between a record backlog and a loss of trust — and as the market has made clear, good news alone is no longer enough to bridge that divide.
Ad
Rheinmetall Stock: New Analysis - 9 July
Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
